February 14, 2024 · Form 4 insider transaction
Van Plew Daniel P sold 200 shares of Regeneron Pharmaceuticals, Inc. at $951.77 per share, a transaction worth $190.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents volume-weighted average price of sales of 200 shares of Company stock on February 14, 2024 at prices ranging from $951.61 to $951.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.